clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel

RxCUI
1540241
RxNorm name
clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel
Display name
clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel
Full name
clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDECLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEBryant Ranch Prepackbe216018-c30d-4184-9152-ae238e3edac42025-10-22Warnings, Adverse reactionsExact identifier
rxcui: 1540241
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDECLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEEncube Ethicals, Inc.8ca01174-431e-449a-a85e-8c68d506776c2025-08-29Warnings, Adverse reactionsExact identifier
rxcui: 1540241
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDECLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEBryant Ranch Prepackabede379-52d1-4000-ae38-cc99f88fe3b22024-04-30Warnings, Adverse reactionsExact identifier
rxcui: 1540241
NeuacCLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEMedimetriks Pharmaceuticalse2cd1c2a-00ee-465e-a4f4-9c0a0bc6266f2023-11-15Warnings, Adverse reactionsExact identifier
rxcui: 1540241
clindamycin phosphate and benzoyl peroxideCLINDAMYCIN, BENZOYL PEROXIDEPadagis Israel Pharmaceuticals Ltd1c7040f2-e503-408a-b07e-72c7972ce78d2023-07-26Warnings, Adverse reactionsExact identifier
rxcui: 1540241
Clindamycin Phosphate and Benzoyl PeroxideCLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEZydus Pharmaceuticals USA Inc.83d52507-99a1-4461-b067-5ec01dc6c5d32022-10-05Warnings, Adverse reactionsExact identifier
rxcui: 1540241

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
abede379-52d1-4000-ae38-cc99f88fe3b2clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]3101These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 200020240430
be216018-c30d-4184-9152-ae238e3edac4clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]3100These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 200020251022
1c7040f2-e503-408a-b07e-72c7972ce78dclindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]38These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, for topical use Initial U.S. Approval: 200020230726
e2cd1c2a-00ee-465e-a4f4-9c0a0bc6266fclindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]33These highlights do not include all the information needed to use Neuac ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5% safely and effectively. See full prescribing information for Neuac ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5%. Neuac ® (CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE) gel, for topical use. Initial U.S. Approval: 200020231115
8ca01174-431e-449a-a85e-8c68d506776cclindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]32These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 200020250829
83d52507-99a1-4461-b067-5ec01dc6c5d3clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY]32These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, 1.2%/5%, for topical use Initial U.S. Approval: 200020221005